Olivier Gouédard
Geschäftsführer bei Cytovia Therapeutics, Inc.
Profil
Olivier Gouédard is currently the Chief Operating Officer at Cytovia Therapeutics, Inc. He holds an MBA from New York University, a doctorate from the University of Rennes, and an undergraduate degree from Université Paris-Saclay.
Aktive Positionen von Olivier Gouédard
| Unternehmen | Position | Beginn |
|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Geschäftsführer | 22.06.2021 |
Ausbildung von Olivier Gouédard
| New York University | Masters Business Admin |
| Université Paris-Saclay | Undergraduate Degree |
| University of Rennes | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |